aspirin has been researched along with osteoprotegerin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y; Wang, J; Wei, J; Zeng, R | 1 |
| Åkerblom, A; Aukrust, P; Becker, RC; Bertilsson, M; Ghukasyan, T; Himmelmann, A; James, SK; Kontny, F; Michelsen, AE; Siegbahn, A; Storey, RF; Ueland, T; Wallentin, L | 1 |
| Liu, X; Ma, L; Sun, G | 1 |
| Tao, ZS; Xu, HG; Yang, M; Zhou, WS | 1 |
1 trial(s) available for aspirin and osteoprotegerin
| Article | Year |
|---|---|
Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Biomarkers; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Osteoprotegerin; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; Up-Regulation | 2018 |
3 other study(ies) available for aspirin and osteoprotegerin
| Article | Year |
|---|---|
Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats.
Topics: Animals; Aspirin; Biomarkers; Bone Density; Calcitonin; Female; Femur; Immunohistochemistry; Lumbar Vertebrae; Osteoporosis; Osteoprotegerin; Ovariectomy; RANK Ligand; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tibia | 2015 |
Aspirin reduces the incidence of postmenopausal osteoporosis in rats through OPG-RANKL-RANK signaling pathway.
Topics: Animals; Aspirin; Bone Density; Cytokines; Female; Humans; Osteoporosis, Postmenopausal; Osteoprotegerin; RANK Ligand; Rats; Rats, Sprague-Dawley; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction; Tomography, X-Ray Computed | 2019 |
Aspirin modified strontium-doped β-tricalcium phosphate can accelerate the healing of femoral metaphyseal defects in ovariectomized rats.
Topics: 3T3 Cells; Animals; Anti-Inflammatory Agents; Aspirin; Bone Density; Bone Morphogenetic Protein 2; Bone Remodeling; Bone Substitutes; Calcium Phosphates; Disease Models, Animal; Female; Femur; Humans; Mice; Osteoblasts; Osteogenesis; Osteoporosis, Postmenopausal; Osteoprotegerin; Ovariectomy; RANK Ligand; Rats, Sprague-Dawley; Signal Transduction; Smad1 Protein; Strontium; Wound Healing | 2020 |